Needs Assessment Tool Fourteen
HP 2010 Goal: Prevent disease, disability, and death from infectious diseases, including vaccine-preventable diseases
HP 2010 Objectives Target Data Assessed Need Recommendations
1.
2.
3.
Reduce or eliminate indigenous cases of vaccine-preventable diseases
Reduce chronic hepatitis B virus infections in infants and young children (perinatal infections)
Reduce hepatitis B
Number of cases:
To 0 for congenital rebella syndrome, diptheria
(under 35 y/o),
Haemophilus influenzae type b (under 5 y/o), measles, mumps, polio
(wild-type virus), rubella,
& tetanus,
(under 35 y/o).
To 9 for ),
Hepatitis B (2-
18 y/o), 2,000 for pertussis
(under 7 y/o),
& 400,000 for varicella
To 400 infections each year
Rate / 100,000:
For adults, 2.4 for ages 19-
24, 5.1 for 25-
39, 3.8 for >
40.

HP 2010 Goal: Prevent disease, disability, and death from infectious diseases, including vaccine-preventable diseases
4.
5.
6.
7.
HP 2010 Objectives
Reduce bacterial meningitis in young children
Reduce invasive pneumococcal infections
Reduce hepatitis A
Reduce meningococcal disease
Target
Tp 1,808 for injection drug users, 1,240 for heterosexually active persons,
1,808 for men who have sex with men, &
62 for occupationally exposed workers
To 8.6 new cases / 100,000 children aged
1-23 months
Rate / 100,000:
New invasive type:
To 46 for < 5 y/0, 42 for >
65 y/o.
Invasive penicillinresistant type:
To 6 for < 6 y/o, 7 for > 65
To 4.5 new cases / 100,000 population
To 1.0 new cases / 100,000 population
Data Assessed Need Recommendations

HP 2010 Goal: Prevent disease, disability, and death from infectious diseases, including vaccine-preventable diseases
8.
9.
10.
HP 2010 Objectives
Reduce Lyme disease
Reduce Hepatitis C
Target
To 9.7 new cases / 100,000 population in endemic States
To 1 new case
/ 100,000 population
Developmental
Data Assessed Need Recommendations
11.
Increae the proportion of persons with chronic hepatitis C infection identified by State and local health departments
Reduce tuberculosis
12.
To 1.0 new case / 100,000 population
To 90% of patients
13.
14.
15.
16.
17.
Increase the proportion of all tuberculosis patients who complete curative therapy within 12 months
Increase the proportion of contacts and other high-risk persons with latent tuberculosis infection who complete a course of treatment
Reduce the average time for a laboratory to confirm and report tuberculosis cases
Increase the proportion of international travelers who receive recommended preventative services when traveling in areas for select infectious diseases: hepatitis A, malaria, typhoid
Reduce invasive early onset group B streptococcal disease
Reduce hospitalizations caused by
To 85%
To 2 days for
75% of cases
Developmental
To 0.5 new cases / 1,000 live births
To 46

HP 2010 Goal: Prevent disease, disability, and death from infectious diseases, including vaccine-preventable diseases
18.
19.
20.
HP 2010 Objectives peptic ulcer disease in the U.S.
Reduce the number of courses of antibiotics for ear infections in young children
Reduce the number of courses of antibiotics prescribed for the sole diagnosis of the common cold
Reduce hospital-acquired infections in intensive care unit patients
Target hospitalization
/ 100,000 population
To 88 antibiotic courses / 100 children < age
5 years
To 1,268 antibiotic courses /
100,000 population
Infections /
1,000 days’ use:
To 5.3 for catheter-assoc. urinary tract infections, 4.8 for central-line
–assoc. bloodstream infection, 10.0 for ventilatorassoc. pneumonia.
And for infants weighing <
1,000 gms or less in intensive care:
11.0 for central-line
Data Assessed Need Recommendations

HP 2010 Goal: Prevent disease, disability, and death from infectious diseases, including vaccine-preventable diseases
21.
22.
23.
24.
HP 2010 Objectives
Reduce antimicrobial use among intensive care unit patients
Achieve and maintain effective vaccination coverage levels for universally recommended vaccines among young children
Maintain vaccination coverage levels for children in licensed day care facilities and children in kindergarten through first grade
Target associated blood stream infection & 4.4 for ventilatorassociated pneumonia
To 120 daily doses / 1,000 patient days
To 90% for all protocols for 4 doses DtaP, 3 doses Hib, 3 doses hepB, 1 dose MMR, 3 doses polio &
I dose varicella vaccines
Developmental for Hepatitis B
& Varicella vaccines; To
95% for DtaP,
MMR, & polio vaccines
To 80% of children 19-35 months
Data Assessed Need Recommendations
25.
Increase the proportion of young children who receive all vaccines that have been recommended for universal administration for at least
5 years
Increase the proportion of providers who have measured the vaccinations coverage levels among children in their practice population within the past 2 years
To 90% for public health and private providers

HP 2010 Goal: Prevent disease, disability, and death from infectious diseases, including vaccine-preventable diseases
26.
27.
28.
HP 2010 Objectives
Increase the proportion of children who participate in fully operational population-based immunization registries
Increase routine vaccinations coverage levels of adolescents
Increase hepatitis B vaccine coverage among high-risk groups
Target
To 95% of children < 6 years
Developmental
Data Assessed Need Recommendations
29.
30.
Increase the proportion of adults who are vaccinated annually against influenza and ever vaccinated against pneumococcal disease
Reduce vaccine-associated adverse events
To 90% for long-term hemodialysis patients, 60% for men who have sex with men, & 98% for occupationally exposed workers
To 90% for noninstitutiona lized adults >
65 y/o; 60% for noninstitutionli zed high-risk adults 18-64b y/o; 90% for institutionalize d adults (in long-term or nursing homes)
To zero cases for vaccineassociated paralytic polio;

HP 2010 Goal: Prevent disease, disability, and death from infectious diseases, including vaccine-preventable diseases
31.
HP 2010 Objectives
Increase the number of persons under active surveillance for vaccine safety via large linked databases
Target
To 75 febrile seizures caused by pertussis vaccine
13 million persons
Data Assessed Need Recommendations